These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11746232)

  • 1. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG binding proteins in the nervous system.
    Fan G; Hutnick L
    Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation.
    Wade PA
    Oncogene; 2001 May; 20(24):3166-73. PubMed ID: 11420733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 and other methyl-CpG binding proteins.
    Jørgensen HF; Bird A
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
    Chandler SP; Guschin D; Landsberger N; Wolffe AP
    Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
    Ohki I; Shimotake N; Fujita N; Nakao M; Shirakawa M
    EMBO J; 1999 Dec; 18(23):6653-61. PubMed ID: 10581239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes in the localization of five members of the methyl binding domain (MBD) gene family during murine and bovine preimplantation embryo development.
    Ruddock-D'Cruz NT; Xue J; Wilson KJ; Heffernan C; Prashadkumar S; Cooney MA; Sanchez-Partida LG; French AJ; Holland MK
    Mol Reprod Dev; 2008 Jan; 75(1):48-59. PubMed ID: 17546630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight interaction between densely methylated DNA fragments and the methyl-CpG binding domain of the rat MeCP2 protein attached to a solid support.
    Shiraishi M; Sekiguchi A; Chuu YH; Sekiya T
    Biol Chem; 1999 Sep; 380(9):1127-31. PubMed ID: 10543452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2: the chromatin connection and beyond.
    Zlatanova J
    Biochem Cell Biol; 2005 Jun; 83(3):251-62. PubMed ID: 15959553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
    Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
    Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recognition of methylated DNA].
    Shirakawa M; Ohki I
    Tanpakushitsu Kakusan Koso; 2002 Aug; 47(10):1268-75. PubMed ID: 12184065
    [No Abstract]   [Full Text] [Related]  

  • 20. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
    Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
    Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.